[
  {
    "ts": null,
    "headline": "Veterinary Infectious Disease Diagnostics Market Forecast, 2025-2035, Featuring IDEXX Labs, Zoetis, Thermo Fisher Scientific, Virbac, bioMerieux and More",
    "summary": "Dublin, Jan. 08, 2026 (GLOBE NEWSWIRE) -- The \"Veterinary Infectious Disease Diagnostics Market - A Global and Regional Analysis: Focus on Technology, Product, Animal Type, Infection Type, End user, Country, and Region - Analysis and Forecast, 2025-2035\" has been added to ResearchAndMarkets.com's offering.One of the key drivers of the veterinary infectious disease diagnostics market is the rising prevalence of zoonotic diseases. Zoonotic diseases those transmitted from animals to humans pose sig",
    "url": "https://finnhub.io/api/news?id=924d278ccaf16139519e734df670449ca817eeef5dc7a329ba161df6e7e2da24",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1767890940,
      "headline": "Veterinary Infectious Disease Diagnostics Market Forecast, 2025-2035, Featuring IDEXX Labs, Zoetis, Thermo Fisher Scientific, Virbac, bioMerieux and More",
      "id": 138038427,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "TMO",
      "source": "Yahoo",
      "summary": "Dublin, Jan. 08, 2026 (GLOBE NEWSWIRE) -- The \"Veterinary Infectious Disease Diagnostics Market - A Global and Regional Analysis: Focus on Technology, Product, Animal Type, Infection Type, End user, Country, and Region - Analysis and Forecast, 2025-2035\" has been added to ResearchAndMarkets.com's offering.One of the key drivers of the veterinary infectious disease diagnostics market is the rising prevalence of zoonotic diseases. Zoonotic diseases those transmitted from animals to humans pose sig",
      "url": "https://finnhub.io/api/news?id=924d278ccaf16139519e734df670449ca817eeef5dc7a329ba161df6e7e2da24"
    }
  },
  {
    "ts": null,
    "headline": "Bio-Techne: Recovery Likely Coming, But Is There Enough Re-Rating Potential?",
    "summary": "Bio-Techne stock has tailwinds in spatial biology and proteomics. Here's what investors need to know.",
    "url": "https://finnhub.io/api/news?id=cfd0ad652fdc70290391587c948a30ae47842583761a57bca9bdc9d008c082d9",
    "source": "SeekingAlpha",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1767878908,
      "headline": "Bio-Techne: Recovery Likely Coming, But Is There Enough Re-Rating Potential?",
      "id": 138038994,
      "image": "https://static.seekingalpha.com/cdn/s3/uploads/getty_images/1158724314/image_1158724314.jpg?io=getty-c-w1536",
      "related": "TMO",
      "source": "SeekingAlpha",
      "summary": "Bio-Techne stock has tailwinds in spatial biology and proteomics. Here's what investors need to know.",
      "url": "https://finnhub.io/api/news?id=cfd0ad652fdc70290391587c948a30ae47842583761a57bca9bdc9d008c082d9"
    }
  },
  {
    "ts": null,
    "headline": "$443.6 Bn Microtome Global Market Trends, Opportunities and Strategies, 2019-2024, 2025-2029F, 2034F: Top 10 Players Hold 26.56% Share Led by Danaher, Thermo Fisher Scientific, and Sakura Finetek",
    "summary": "Key opportunities in the microtome market lie in expanding technical centers for innovation, focusing on next-gen microtomes and automation to enhance precision, and tapping into emerging markets. Growth is driven by disease diagnosis and drug discovery needs, with the accessories and fully automated segments showing promise. Microtome Market Microtome Market Dublin, Jan. 08, 2026 (GLOBE NEWSWIRE) -- The \"Microtome Global Market Opportunities and Strategies to 2034\" has been added to ResearchAnd",
    "url": "https://finnhub.io/api/news?id=c0a8b706cf96680af772b57174884658f0b70c98c12a6c3b9de37c72bad122ed",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1767873060,
      "headline": "$443.6 Bn Microtome Global Market Trends, Opportunities and Strategies, 2019-2024, 2025-2029F, 2034F: Top 10 Players Hold 26.56% Share Led by Danaher, Thermo Fisher Scientific, and Sakura Finetek",
      "id": 138035024,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "TMO",
      "source": "Yahoo",
      "summary": "Key opportunities in the microtome market lie in expanding technical centers for innovation, focusing on next-gen microtomes and automation to enhance precision, and tapping into emerging markets. Growth is driven by disease diagnosis and drug discovery needs, with the accessories and fully automated segments showing promise. Microtome Market Microtome Market Dublin, Jan. 08, 2026 (GLOBE NEWSWIRE) -- The \"Microtome Global Market Opportunities and Strategies to 2034\" has been added to ResearchAnd",
      "url": "https://finnhub.io/api/news?id=c0a8b706cf96680af772b57174884658f0b70c98c12a6c3b9de37c72bad122ed"
    }
  },
  {
    "ts": null,
    "headline": "How The Narrative Around Thermo Fisher Scientific (TMO) Is Shifting After Q3 And New Forecasts",
    "summary": "Why Thermo Fisher’s Fair Value Estimate Just Nudged Higher Thermo Fisher Scientific’s fair value estimate has been revised slightly higher, moving from about US$625.87 to roughly US$641.57, while the discount rate and long term revenue growth assumptions are essentially unchanged. This reflects Street research that has turned somewhat more constructive after a Q3 update described as strong or in line, with analysts highlighting consistent execution, Thermo Fisher’s scale in life science...",
    "url": "https://finnhub.io/api/news?id=bdc6c886e33528ea99d8436fbc8590c9713588804721d2819c6a0b4f458666d3",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1767852629,
      "headline": "How The Narrative Around Thermo Fisher Scientific (TMO) Is Shifting After Q3 And New Forecasts",
      "id": 138033233,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "TMO",
      "source": "Yahoo",
      "summary": "Why Thermo Fisher’s Fair Value Estimate Just Nudged Higher Thermo Fisher Scientific’s fair value estimate has been revised slightly higher, moving from about US$625.87 to roughly US$641.57, while the discount rate and long term revenue growth assumptions are essentially unchanged. This reflects Street research that has turned somewhat more constructive after a Q3 update described as strong or in line, with analysts highlighting consistent execution, Thermo Fisher’s scale in life science...",
      "url": "https://finnhub.io/api/news?id=bdc6c886e33528ea99d8436fbc8590c9713588804721d2819c6a0b4f458666d3"
    }
  }
]